- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/02 - Drugs for genital or sexual disordersContraceptives for disorders of the vagina
Patent holdings for IPC class A61P 15/02
Total number of patents in this class: 536
10-year publication summary
|
13
|
14
|
29
|
42
|
49
|
48
|
42
|
41
|
53
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Polichem SA | 193 |
8 |
| Osel, Inc. | 15 |
7 |
| Kimberly-clark Worldwide, Inc. | 5430 |
6 |
| Ferring B.V. | 709 |
6 |
| Lakewood-amedex, Inc. | 31 |
6 |
| Singapore Ze&z International Pte. Ltd. | 9 |
6 |
| The Johns Hopkins University | 5730 |
5 |
| Takeda Pharmaceutical Company Limited | 2704 |
5 |
| Daré BioScience, Inc. | 34 |
5 |
| Probiotical S.p.A. | 227 |
5 |
| TherapeuticsMD, Inc. | 107 |
5 |
| Freya Biosciences ApS | 13 |
5 |
| ITF Research Pharma, S.L.U. | 20 |
4 |
| Lesaffre et Compagnie | 838 |
4 |
| Lunamed AG | 13 |
4 |
| Scynexis, Inc. | 67 |
4 |
| University of Rochester | 1318 |
4 |
| Reckitt Benckiser Health Limited | 324 |
4 |
| Mucosa Innovations, S.L. | 11 |
4 |
| Profem GmbH | 10 |
4 |
| Other owners | 435 |